Donna Faletto

Title: The Innovations of Donna Faletto

Introduction

Donna Faletto is a prominent inventor based in Mt. Airy, MD (US). She has made significant contributions to the field of cancer research, particularly in understanding breast cancer progression. With a total of 2 patents, her work has had a profound impact on diagnostic methods and therapeutic approaches.

Latest Patents

Faletto's latest patents include groundbreaking inventions related to the MET proto-oncogene. One patent focuses on a method for predicting breast cancer progression by determining the amount of met protein in tumor tissue relative to normal breast duct tissue. Another patent involves a complex comprising hepatocyte growth factor (HGF) and met proto-oncogene protein. This invention also details methods for detecting the presence of HGF ligand and met proto-oncogene receptor, as well as methods for isolating these components. These innovations are crucial for diagnosing proliferative disorders and diseases such as hepatitis and hepatocarcinogenesis.

Career Highlights

Throughout her career, Donna Faletto has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the National Institutes of Health, a component of the US Department of Health & Human Services. Her work has been instrumental in advancing cancer research and improving diagnostic techniques.

Collaborations

Faletto has collaborated with notable colleagues in her field, including George F. Vande Woude and Donald P. Bottaro. These partnerships have further enhanced her research and contributed to the success of her inventions.

Conclusion

Donna Faletto's contributions to cancer research through her innovative patents have significantly advanced the understanding of breast cancer progression. Her work continues to influence the field and offers hope for improved diagnostic methods and treatments.